Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20:(5)533-534

Eaton L. Covid-19: WHO warns against “vaccine nationalism” or face further virus mutations. BMJ. 2021; 372

English PM. The UK approach to COVID-19 vaccination: why was it so different?. Drugs Context. 2021; 10

Harris RJ, Hall JA, Zaidi A, Andrews NJ, Dunbar JK, Dabrera G. Effect of vaccination on household transmission of SARS-CoV-2 in England. N Engl J Med. 2021; 385:(8)759-760

Healthwatch. Getting to vaccine centres more of a barrier for Black communities. 2021. (accessed 28 September 2021)

Jennings W, Stoker G, Bunting H Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines (Basel). 2021; 9:(6)

Joint Committee on Vaccination and Immunisation. JCVI statement, September 2021: COVID-19 booster vaccine programme for winter 2021 to 2022. 2021. (accessed 28 September 2021)

NHS England. Statistics. COVID-19 vaccinations. (accessed 28 September 2021)

NIHR Policy Research Unit in Behavioural Science. Factors associated with vaccine intention in adults living in England who either do not want or have not yet decided whether to be vaccinated against COVID-19. 2020. (accessed 28 September 2021)

Public Health England. COVID-19 vaccine surveillance report - week 38. 2021. (accessed 28 September 2021)

Robertson E, Reeve KS, Niedzwiedz CL Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021; 94:41-50

Sherman SM, Smith LE, Sim J COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021; 17:(6)1612-1621

Shrotri M, Navaratnam AMD, Nguyen V Spike-antibody waning after second dose of BNT162b2 or ChAdOx1. Lancet. 2021; 398:(10298)385-387

Voysey M, Costa Clemens SA, Madhi SA Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021; 397:(10277)881-891

Wagner CE, Saad-Roy CM, Morris SE Vaccine nationalism and the dynamics and control of SARS-CoV-2. Science. 2021; 373:(6562)

Strategies for gradually lifting NPIs in parallel to COVID-19 vaccine roll out in the UK. S1078_SPI-M. 2021. (accessed 28 September 2021)

Zoe. Is COVID vaccine protection fading?. 2021. (accessed 28 September 2021)

COVID vaccination: What's next?

02 October 2021
Volume 32 · Issue 10


Dr Catherine Heffernan looks at the story so far, and what the future holds for the COVID-19 vaccine rollout

The COVID-19 pandemic (caused by the SARS-CoV-2 virus) has led to more than 180 million infections and 4 million deaths worldwide (Dong et al, 2021). Since December 2020, effective vaccines have been available and deployed in the UK (NHS England, 2021). By 19 September 2021, a total of 77 510 471 doses of COVID-19 vaccine had been given in England. Over 37 million of these were second doses (Public Health England, 2021). This equates to 64.9% overall uptake for first dose and 59.5% for the second dose. Public Health England estimated that over 119 900 deaths and 24 million infections were prevented. Over 230 800 hospitalisations were averted.

In line with the programme rollout, coverage is highest in the oldest age groups. Over 95% of people aged 55 and older are fully vaccinated with two doses whilst uptake is 47.3% in 30–34 age group and 61% in 35-39 years (NHS England, 2021). COVID-19 vaccination was also seen to reduce onward transmission in a household by a third to a half where the confirmed case had been vaccinated with a single dose (Harris et al, 2021).

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month